SureTrader
Home > Boards > US Listed > Biotechs >

Enanta Pharmaceuticals (ENTA)

ENTA RSS Feed
Add ENTA Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board:
Last Post: 2/12/2016 7:10:43 PM - Followers: 64 - Board type: Free - Posts Today: 0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENTA
Current Price
Volume:
Bid Ask Day's Range
Wiki
ENTA News: Statement of Changes in Beneficial Ownership (4) 02/12/2016 04:11:18 PM
ENTA News: Statement of Changes in Beneficial Ownership (4) 02/12/2016 04:10:04 PM
ENTA News: Amended Statement of Ownership (sc 13g/a) 02/12/2016 09:09:21 AM
ENTA News: Current Report Filing (8-k) 02/08/2016 04:14:16 PM
ENTA News: Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2015 02/08/2016 04:02:00 PM
News News Alert: Statement of Changes in Beneficial Ownership (4) 02/12/2016 04:11:18 PM
PostSubject
#1310  Sticky Note ENTA FY1Q16 EPS=$1.36—cash*=$254.5: DewDiligence 02/08/16 04:34:13 PM
#1323   Canada trying to save a few bucks with NY1972 02/12/16 07:10:43 PM
#1322   Express Scripts' Miller likes price for Merck hepatitis drug NY1972 02/12/16 06:08:32 PM
#1321   Fidelity sold a little ENTA, down to 3.93% biotech_researcher 02/12/16 12:54:41 PM
#1320   Sounds like a non sequitur. DewDiligence 02/11/16 12:51:31 PM
#1319   Shorts' most favorite analyst? NY1972 02/11/16 12:48:01 PM
#1318   Shorts got shorter, must be convinced Z = NY1972 02/09/16 11:20:11 PM
#1317   The FY1Q16 10-Q has been filed: DewDiligence 02/09/16 07:09:20 PM
#1316   I think that the focus should be on Rocky3 02/09/16 06:14:19 PM
#1315   Will Japan 2D regiment bring in 200M next NY1972 02/09/16 11:20:31 AM
#1314   The word, unfortunately in that context means unfortunately DewDiligence 02/09/16 08:33:55 AM
#1313   Luly's Unfortunate view on Merck's label: NY1972 02/08/16 11:47:06 PM
#1312   It helps that the expected tax rate in DewDiligence 02/08/16 07:49:18 PM
#1311   P/E = 5??? Rocky3 02/08/16 05:36:22 PM
#1310   ENTA FY1Q16 EPS=$1.36—cash*=$254.5: DewDiligence 02/08/16 04:34:13 PM
#1308   P/E = 5 NY1972 02/08/16 02:12:40 PM
#1307  Restored Remicade, Humira and Enbrel work by blocking an biotech_researcher 02/05/16 07:43:51 PM
#1306   What will be ZEPATIER real world cure rate NY1972 02/03/16 10:03:07 AM
#1305   5-year recurrence risk after achieving SVR NY1972 02/02/16 10:38:53 PM
#1304   ENTA longs are running away from the falling NY1972 02/01/16 05:57:17 PM
#1303   See #msg-120230722. DewDiligence 02/01/16 04:23:59 PM
#1302   They have pretty much toasted ENTA; discounting away biotech_researcher 02/01/16 04:05:58 PM
#1301   As RAV screening may be hit or miss NY1972 02/01/16 01:29:16 PM
#1300   See #msg-117023180 (eom). DewDiligence 02/01/16 11:23:54 AM
#1299   Will BMY withdraw from Japan or lower price 50%? NY1972 02/01/16 11:18:36 AM
#1298   The detailed pivotal data are in Section 14 DewDiligence 01/31/16 09:09:15 AM
#1297   Will EMA give MRK a different label? No NY1972 01/30/16 11:07:33 PM
#1296   ENTA's royalty rate is 50% higher in Japan—see #msg-120167636. DewDiligence 01/29/16 10:23:04 AM
#1295   ENTA will receive at least 159 mil from NY1972 01/29/16 10:21:09 AM
#1294   4Q15 V-Pak sales $554M: #msg-120164111. DewDiligence 01/29/16 07:59:13 AM
#1293   EDP-494 to treat Zika, West Nile virus (WNV), NY1972 01/28/16 11:33:13 PM
#1292   Simple screening may not be accurate. NY1972 01/28/16 08:59:34 PM
#1291   FDA approves MRK’s HCV combo with recommended RAV DewDiligence 01/28/16 06:26:35 PM
#1290   ENTA- BlackRock reported holding 8.9% of ENTA as biotech_researcher 01/28/16 04:55:05 PM
#1289   ENTA’s FY1Q16 results/CC on 2/9/16: DewDiligence 01/28/16 08:14:16 AM
#1288   How many non-nucleoside NS5B polymerase inhibitors are available? NY1972 01/21/16 02:12:42 PM
#1287   Today's +13% move likely due (at least in DewDiligence 01/20/16 04:58:16 PM
#1286   CSO exercised and held more options yesterday: #msg-119968598. DewDiligence 01/20/16 04:55:48 PM
#1285   Some of the disparity comes from the different DewDiligence 01/20/16 02:29:10 PM
#1284   Dewophile predicted a label similar to what olysio NY1972 01/20/16 12:43:26 PM
#1283   Why is GT3 cirrhotics excluded in EXPEDITION-1? GT3 DewDiligence 01/17/16 08:30:25 PM
#1282   Why is GT3 cirrhotics excluded in EXPEDITION 1? NY1972 01/17/16 04:30:57 PM
#1281   Global phase-3 program for ABT-493/ABT-530 (updated for EXPEDITION-4): DewDiligence 01/17/16 01:39:18 PM
#1280   4 million shares shorted @ 12/31/2015. SS expects NY1972 01/16/16 12:51:46 AM
#1279   Look at how much respect ACHN got with NY1972 01/15/16 11:08:39 AM
#1278   Well, we will see. First it has to willyw 01/15/16 08:53:37 AM
#1277   -------------------- There is a lot of data on Sovaldi, NY1972 01/14/16 10:10:45 PM
#1276   Thanks for the compliment, but I'm not a willyw 01/14/16 04:19:22 PM
#1275   If EDP-494 wipes out NS5B RAVs as shown NY1972 01/14/16 03:01:53 PM
#1274   The textbook answer is what Luly said; A willyw 01/14/16 01:27:48 PM
#1273   ENTA wants EDP-484 to be used in a DewDiligence 01/14/16 12:50:58 PM
PostSubject